Disparities Exist in Outpatient Referrals for Opioid Use Disorder

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 8, 2025.

via HealthDay

MONDAY, July 7, 2025 -- Black patients presenting to the emergency department for an opioid overdose are less likely to receive outpatient referrals for opioid use disorder (OUD), according to a study published online July 2 in JAMA Network Open.

Siri Shastry, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined racial and ethnic disparities in treatment referral rates in emergency department patients with opioid overdose. The analysis included data from 10 hospital sites (1,683 patients) participating in the Toxicology Investigators Consortium Fentalog Study (Sept. 21, 2020, to Nov. 11, 2023).

The researchers found that 17.8 percent of patients presenting to the emergency department received a referral for outpatient treatment, 42.4 percent received a naloxone kit or prescription, and 8.4 percent received a buprenorphine prescription. Black patients had a decreased likelihood of outpatient treatment referral (adjusted odds ratio, 0.67) compared with White patients. Hospital admission was associated with an increased likelihood of outpatient treatment referral (adjusted odds ratio, 3.13). There was geographic variation noted for all primary and secondary outcomes.

"In this study, Black patients were less likely to receive outpatient referrals for OUD," the authors write. "These findings underscore the need for targeted interventions to address racial disparities in emergency department care for OUD, particularly in enhancing referral processes."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-09 00:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords